Structured Review

Durect Corporation 2002 osmotic minipump
2002 Osmotic Minipump, supplied by Durect Corporation, used in various techniques. Bioz Stars score: 85/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/2002 osmotic minipump/product/Durect Corporation
Average 85 stars, based on 1 article reviews
Price from $9.99 to $1999.99
2002 osmotic minipump - by Bioz Stars, 2020-07
85/100 stars

Images

Related Articles

Recombinant:

Article Title: Selective Effects of Nerve Growth Factor on Spatial Recent Memory as Assessed by a Delayed Nonmatching-to-Position Task in the Water Maze
Article Snippet: .. The cannula was connected to an Alzet 2002 osmotic minipump (Alzet Corporation, Palo Alto, CA) and filled with either recombinant human NGF (40 μg of NGF per pump) (Genentech, San Francisco, CA) or with artificial CSF (210 μl/pump). ..

other:

Article Title: Therapeutic Effects of the Superoxide Dismutase Mimetic Compound MnIIMe2DO2A on Experimental Articular Pain in Rats
Article Snippet: To evaluate its preventive effect, MnL4 was administered by continuous s.c. infusion, from day 0 to day 14, using the Alzet 2002 osmotic minipump (15 mg kg−1 day).

Article Title: Ciliary neurotrophic factor promotes motor reinnervation of the musculocutaneous nerve in an experimental model of end-to-side neurorrhaphy
Article Snippet: The cannula was introduced to the depth of 3.8-4 mm and connected using a polyethylene catheter tube with an ALZET 2002 osmotic minipump (rate 0.5 μl/h, 2 weeks) implanted subcutaneously in the back of the rat.

Mouse Assay:

Article Title: Modified Peptide YY Molecule Attenuates the Activity of NPY/AgRP Neurons and Reduces Food Intake in Male Mice
Article Snippet: .. DIO mice received subcutaneous implants of an Alzet 2002 osmotic minipump (Durect, Cupertino, CA). .. All of the DIO mice experienced a small reduction in body weight following implantation of the minipump.

Similar Products

  • Logo
  • About
  • News
  • Press Release
  • Team
  • Advisors
  • Partners
  • Contact
  • Bioz Stars
  • Bioz vStars
  • 92
    Durect Corporation alzet osmotic minipumps
    UII induces the activation of c-Jun N -terminal kinase (JNK) in cardiac side population cells (CSPs) during pressure overload. ( A ) Phospho-JNK was detected in CSPs isolated from transverse aorta constriction (TAC) or Sham mice by nanofluidic proteomic immunoassay (NIA). ( B ) NIA pseudoblot representation of phospho-JNK and bar graph of p-JNK/GAPDH in isolated CSPs by NIA quantification. Urantide (30 μg/kg/day) or vehicle were, respectively, continuously administered by <t>Alzet</t> osmotic <t>minipumps</t> to mice from 2 to 4 weeks after TAC or sham operation, then CSPs were isolated from heart by fluorescence-activated cell sorting for NIA with antibody to phosphos-JNK. Values are expressed as mean ± SEM. Sham: n = 9; Sham+Ura: n = 6; TAC: n = 6; TAC+Ura: n = 7. Ura: urantide. * P
    Alzet Osmotic Minipumps, supplied by Durect Corporation, used in various techniques. Bioz Stars score: 92/100, based on 303 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/result/alzet osmotic minipumps/product/Durect Corporation
    Average 92 stars, based on 303 article reviews
    Price from $9.99 to $1999.99
    alzet osmotic minipumps - by Bioz Stars, 2020-07
    92/100 stars
      Buy from Supplier

    Image Search Results


    UII induces the activation of c-Jun N -terminal kinase (JNK) in cardiac side population cells (CSPs) during pressure overload. ( A ) Phospho-JNK was detected in CSPs isolated from transverse aorta constriction (TAC) or Sham mice by nanofluidic proteomic immunoassay (NIA). ( B ) NIA pseudoblot representation of phospho-JNK and bar graph of p-JNK/GAPDH in isolated CSPs by NIA quantification. Urantide (30 μg/kg/day) or vehicle were, respectively, continuously administered by Alzet osmotic minipumps to mice from 2 to 4 weeks after TAC or sham operation, then CSPs were isolated from heart by fluorescence-activated cell sorting for NIA with antibody to phosphos-JNK. Values are expressed as mean ± SEM. Sham: n = 9; Sham+Ura: n = 6; TAC: n = 6; TAC+Ura: n = 7. Ura: urantide. * P

    Journal: Journal of Cellular and Molecular Medicine

    Article Title: Urotensin II inhibited the proliferation of cardiac side population cells in mice during pressure overload by JNK-LRP6 signalling

    doi: 10.1111/jcmm.12230

    Figure Lengend Snippet: UII induces the activation of c-Jun N -terminal kinase (JNK) in cardiac side population cells (CSPs) during pressure overload. ( A ) Phospho-JNK was detected in CSPs isolated from transverse aorta constriction (TAC) or Sham mice by nanofluidic proteomic immunoassay (NIA). ( B ) NIA pseudoblot representation of phospho-JNK and bar graph of p-JNK/GAPDH in isolated CSPs by NIA quantification. Urantide (30 μg/kg/day) or vehicle were, respectively, continuously administered by Alzet osmotic minipumps to mice from 2 to 4 weeks after TAC or sham operation, then CSPs were isolated from heart by fluorescence-activated cell sorting for NIA with antibody to phosphos-JNK. Values are expressed as mean ± SEM. Sham: n = 9; Sham+Ura: n = 6; TAC: n = 6; TAC+Ura: n = 7. Ura: urantide. * P

    Article Snippet: From 2 to 4 weeks after TAC, urantide (30 μg/kg/day, Peptides International Inc., Louisville, KY, USA) or vehicle were respectively continuously administered by Alzet osmotic minipumps (Model 2002; DURECT, Cupertino, CA, USA) implanted subcutaneously into the back of mice.

    Techniques: Activation Assay, Isolation, Mouse Assay, Fluorescence, FACS

    Urantide doesn*t affect the phosphorylation of extracellular signal-regulated kinas (ERK) in cardiac side population cells (CSPs) in pressure overload mice. ( A ) Multiple isoforms of Phospho-ERK was detected in CSPs by nanofluidic proteomic immunoassay (NIA). Peaks on the traces that represent phosphorylated isoforms are indicated. ( B ) NIA pseudoblot representation of ERK. ( C ) Bar graph of tp-ERK1/tERK1 by NIA quantification. tp-ERK1: total phosphorylation of ERK1. tERK1: total ERK1. ( D ) Bar graph of tp-ERK2/ERK2 by NIA quantification. tp-ERK2: total phosphorylation of ERK2. tERK2: total ERK2. Urantide (30 μg/kg/day) or vehicle were respectively continuously administered by Alzet osmotic minipumps to mice from 2 to 4 weeks after transverse aorta constriction (TAC) or sham operation, then CSPs were isolated from heart by fluorescence-activated cell sorting for NIA with antibody to phosphos-ERK. Values are expressed as mean ± SEM. Sham: n = 9. Sham+Ura: n = 6. TAC: n = 6. TAC+Ura: n = 7. Ura:urantide. * P

    Journal: Journal of Cellular and Molecular Medicine

    Article Title: Urotensin II inhibited the proliferation of cardiac side population cells in mice during pressure overload by JNK-LRP6 signalling

    doi: 10.1111/jcmm.12230

    Figure Lengend Snippet: Urantide doesn*t affect the phosphorylation of extracellular signal-regulated kinas (ERK) in cardiac side population cells (CSPs) in pressure overload mice. ( A ) Multiple isoforms of Phospho-ERK was detected in CSPs by nanofluidic proteomic immunoassay (NIA). Peaks on the traces that represent phosphorylated isoforms are indicated. ( B ) NIA pseudoblot representation of ERK. ( C ) Bar graph of tp-ERK1/tERK1 by NIA quantification. tp-ERK1: total phosphorylation of ERK1. tERK1: total ERK1. ( D ) Bar graph of tp-ERK2/ERK2 by NIA quantification. tp-ERK2: total phosphorylation of ERK2. tERK2: total ERK2. Urantide (30 μg/kg/day) or vehicle were respectively continuously administered by Alzet osmotic minipumps to mice from 2 to 4 weeks after transverse aorta constriction (TAC) or sham operation, then CSPs were isolated from heart by fluorescence-activated cell sorting for NIA with antibody to phosphos-ERK. Values are expressed as mean ± SEM. Sham: n = 9. Sham+Ura: n = 6. TAC: n = 6. TAC+Ura: n = 7. Ura:urantide. * P

    Article Snippet: From 2 to 4 weeks after TAC, urantide (30 μg/kg/day, Peptides International Inc., Louisville, KY, USA) or vehicle were respectively continuously administered by Alzet osmotic minipumps (Model 2002; DURECT, Cupertino, CA, USA) implanted subcutaneously into the back of mice.

    Techniques: Mouse Assay, Isolation, Fluorescence, FACS

    UII inhibits cardiac side population cells (CSPs) proliferation by UT during pressure overload. ( A ) The ratio of CSPs per mouse was analysed by fluorescence-activated cell sorting (FACS). Representative photographs are shown. ( B ) The ratio of CSPs per mouse was calculated by FACS. Urantide (30 μg/kg/day) or vehicle were, respectively, continuously administered by Alzet osmotic minipumps to mice from 2 to 4 weeks after transverse aorta constriction (TAC) or sham operation. ( C ) Plasma UII level was examined with ELISA analysis. Values are expressed as mean ± SEM. Sham: n = 9; Sham+Ura: n = 6; TAC: n = 6; TAC+Ura: n = 7. Ura: urantide. * P

    Journal: Journal of Cellular and Molecular Medicine

    Article Title: Urotensin II inhibited the proliferation of cardiac side population cells in mice during pressure overload by JNK-LRP6 signalling

    doi: 10.1111/jcmm.12230

    Figure Lengend Snippet: UII inhibits cardiac side population cells (CSPs) proliferation by UT during pressure overload. ( A ) The ratio of CSPs per mouse was analysed by fluorescence-activated cell sorting (FACS). Representative photographs are shown. ( B ) The ratio of CSPs per mouse was calculated by FACS. Urantide (30 μg/kg/day) or vehicle were, respectively, continuously administered by Alzet osmotic minipumps to mice from 2 to 4 weeks after transverse aorta constriction (TAC) or sham operation. ( C ) Plasma UII level was examined with ELISA analysis. Values are expressed as mean ± SEM. Sham: n = 9; Sham+Ura: n = 6; TAC: n = 6; TAC+Ura: n = 7. Ura: urantide. * P

    Article Snippet: From 2 to 4 weeks after TAC, urantide (30 μg/kg/day, Peptides International Inc., Louisville, KY, USA) or vehicle were respectively continuously administered by Alzet osmotic minipumps (Model 2002; DURECT, Cupertino, CA, USA) implanted subcutaneously into the back of mice.

    Techniques: Fluorescence, FACS, Mouse Assay, Enzyme-linked Immunosorbent Assay